- Home
- XCUR vs TURN Comparison
XCUR vs TURN Comparison
Compare XCUR & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- TURN
- Stock Information
- Founded
- XCUR 2011
- TURN 1981
- Country
- XCUR United States
- TURN United States
- Employees
- XCUR N/A
- TURN N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- XCUR Health Care
- TURN Finance
- Exchange
- XCUR Nasdaq
- TURN Nasdaq
- Market Cap
- XCUR 43.6M
- TURN 39.6M
- IPO Year
- XCUR N/A
- TURN N/A
- Fundamental
- Price
- XCUR $13.22
- TURN $3.72
- Analyst Decision
- XCUR
- TURN
- Analyst Count
- XCUR 0
- TURN 0
- Target Price
- XCUR N/A
- TURN N/A
- AVG Volume (30 Days)
- XCUR 47.7K
- TURN 38.0K
- Earning Date
- XCUR 11-14-2024
- TURN 05-12-2025
- Dividend Yield
- XCUR N/A
- TURN N/A
- EPS Growth
- XCUR N/A
- TURN N/A
- EPS
- XCUR N/A
- TURN N/A
- Revenue
- XCUR $500,000.00
- TURN $194,813.00
- Revenue This Year
- XCUR N/A
- TURN N/A
- Revenue Next Year
- XCUR N/A
- TURN N/A
- P/E Ratio
- XCUR N/A
- TURN N/A
- Revenue Growth
- XCUR N/A
- TURN 254.25
- 52 Week Low
- XCUR $1.44
- TURN $3.12
- 52 Week High
- XCUR $36.00
- TURN $4.40
- Technical
- Relative Strength Index (RSI)
- XCUR 59.25
- TURN 36.71
- Support Level
- XCUR $10.10
- TURN $3.67
- Resistance Level
- XCUR $14.44
- TURN $3.90
- Average True Range (ATR)
- XCUR 1.86
- TURN 0.11
- MACD
- XCUR 0.38
- TURN -0.03
- Stochastic Oscillator
- XCUR 72.77
- TURN 28.26
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.